Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metastases
NCT05419518Phase 2Recruiting
- Sponsor
- Rutgers University
- Start
- Mar 2023
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 2, open-label trial (2 arms), sponsored by Rutgers University. Primary endpoint: Number of participants experiencing adverse events at 1 month. Started Mar 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05419518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05419518.